Business Description
Exact Sciences Corp
NAICS : 621511
SIC : 8731
ISIN : US30063P1057
Description
Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a non-invasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a genetic-based treatment selection test for breast, prostate, and colon cancers. With the acquisitions of Base Genomics and Thrive Earlier Detection, Exact is building a multi-cancer early screening test to detect over 14 cancers, a test that would be one of the earliest entrants in multi-cancer liquid biopsy cancer screening.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.3 | |||||
| Equity-to-Asset | 0.48 | |||||
| Debt-to-Equity | 0.84 | |||||
| Debt-to-EBITDA | -11.8 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.82 | |||||
| Beneish M-Score | -2.86 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 21 | |||||
| 3-Year EBITDA Growth Rate | 3.4 | |||||
| 3-Year EPS without NRI Growth Rate | -29.8 | |||||
| 3-Year FCF Growth Rate | -4.7 | |||||
| 3-Year Book Growth Rate | 3.3 | |||||
| Future 3-5Y Total Revenue Growth Rate | 15.51 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 8.25 | |||||
| 9-Day RSI | 17.29 | |||||
| 14-Day RSI | 24.21 | |||||
| 6-1 Month Momentum % | 27.57 | |||||
| 12-1 Month Momentum % | 138.31 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.41 | |||||
| Quick Ratio | 2.14 | |||||
| Cash Ratio | 1.59 | |||||
| Days Inventory | 72.28 | |||||
| Days Sales Outstanding | 28.41 | |||||
| Days Payable | 46.08 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.4 | |||||
| Shareholder Yield % | -0.63 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 73.53 | |||||
| Operating Margin % | -17.44 | |||||
| Net Margin % | -18.76 | |||||
| ROE % | -13.95 | |||||
| ROA % | -6.82 | |||||
| ROIC % | -7.45 | |||||
| ROC (Joel Greenblatt) % | -48.55 | |||||
| ROCE % | -7.04 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 5.23 | |||||
| PB Ratio | 3.95 | |||||
| Price-to-Operating-Cash-Flow | 166.01 | |||||
| EV-to-EBIT | -34.55 | |||||
| EV-to-Forward-EBIT | -233.08 | |||||
| EV-to-EBITDA | -66.1 | |||||
| EV-to-Forward-EBITDA | 93.16 | |||||
| EV-to-Revenue | 6.24 | |||||
| EV-to-Forward-Revenue | 5.08 | |||||
| EV-to-FCF | -138.2 | |||||
| Price-to-Median-PS-Value | 0.23 | |||||
| Earnings Yield (Greenblatt) % | -2.89 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:EXAS
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Exact Sciences Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 2,300.611 | ||
| EPS (TTM) ($) | -2.43 | ||
| Beta | 1.02 | ||
| Volatility % | 56.24 | ||
| 14-Day RSI | 24.21 | ||
| 14-Day ATR ($) | 2.505977 | ||
| 20-Day SMA ($) | 79.0665 | ||
| 12-1 Month Momentum % | 138.31 | ||
| 52-Week Range ($) | 29.27 - 100.77 | ||
| Shares Outstanding (Mil) | 180.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Exact Sciences Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Exact Sciences Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Exact Sciences Corp Frequently Asked Questions
What is Exact Sciences Corp(EXAS)'s stock price today?
The current price of EXAS is $66.85. The 52 week high of EXAS is $100.77 and 52 week low is $29.27.
When is next earnings date of Exact Sciences Corp(EXAS)?
The next earnings date of Exact Sciences Corp(EXAS) is 2023-11-03 Est..
Does Exact Sciences Corp(EXAS) pay dividends? If so, how much?
Exact Sciences Corp(EXAS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers